BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui Q, Wang J, Assaraf YG, Ren L, Gupta P, Wei L, Ashby CR, Yang D, Chen Z. Modulating ROS to overcome multidrug resistance in cancer. Drug Resistance Updates 2018;41:1-25. [DOI: 10.1016/j.drup.2018.11.001] [Cited by in Crossref: 251] [Cited by in F6Publishing: 273] [Article Influence: 62.8] [Reference Citation Analysis]
Number Citing Articles
1 Xie Y, Feng S, He F, Yan P, Yao X, Fan X, Leung EL, Zhou H. Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer. Pharmacological Research 2022;186:106514. [DOI: 10.1016/j.phrs.2022.106514] [Reference Citation Analysis]
2 Zhao H, Li Y, Shi H, Niu M, Li D, Zhang Z, Feng Q, Zhang Y, Wang L. Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress. Journal of Controlled Release 2022;352:909-919. [DOI: 10.1016/j.jconrel.2022.11.011] [Reference Citation Analysis]
3 Shen C, Yue X, Dai L, Wang J, Li J, Fang Q, Zhi Y, Shi C, Li W. Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04385-4] [Reference Citation Analysis]
4 Tavleeva MM, Belykh ES, Rybak AV, Rasova EE, Chernykh AA, Ismailov ZB, Velegzhaninov IO. Effects of Antioxidant Gene Overexpression on Stress Resistance and Malignization In Vitro and In Vivo: A Review. Antioxidants 2022;11:2316. [DOI: 10.3390/antiox11122316] [Reference Citation Analysis]
5 Peña Q, Rodríguez-calado S, Simaan AJ, Capdevila M, Bayón P, Palacios O, Lorenzo J, Iranzo O. Cell-penetrating peptide-conjugated copper complexes for redox-mediated anticancer therapy. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1060827] [Reference Citation Analysis]
6 Haslem L, Hays JM, Zhang XA, Hays FA. P66Shc (Shc1) Zebrafish Mutant Line as a Platform for Testing Decreased Reactive Oxygen Species in Pathology. JCDD 2022;9:385. [DOI: 10.3390/jcdd9110385] [Reference Citation Analysis]
7 Hu J, Bian Q, Ma X, Xu Y, Gao J. A double-edged sword: ROS related therapies in the treatment of psoriasis. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2022.10.005] [Reference Citation Analysis]
8 Zhang K, Zhang D, Wang J, Wang Y, Hu J, Zhou Y, Zhou X, Nie S, Xie M. Aloe gel glucomannan induced colon cancer cell death via mitochondrial damage-driven PINK1/Parkin mitophagy pathway. Carbohydrate Polymers 2022;295:119841. [DOI: 10.1016/j.carbpol.2022.119841] [Reference Citation Analysis]
9 Chen Y, Zhang S, Cheng T, Lin W, Mao L, Chen Z, Yang Y, Huang H, Li J, Ke Z, Cui Z. Design and development of a mitochondrial-targeted photosensitizer for two-photon fluorescence imaging and photodynamic therapy. Journal of Materials Science & Technology 2022. [DOI: 10.1016/j.jmst.2022.09.022] [Reference Citation Analysis]
10 Gao Z, Zheng S, Kamei K, Tian C. Recent progress in cancer therapy based on the combination of ferroptosis with photodynamic therapy. Acta Materia Medica 2022;1. [DOI: 10.15212/amm-2022-0025] [Reference Citation Analysis]
11 Cui Q, Ding W, Liu P, Luo B, Yang J, Lu W, Hu Y, Huang P, Wen S. Developing Bi-Gold Compound BGC2a to Target Mitochondria for the Elimination of Cancer Cells. IJMS 2022;23:12169. [DOI: 10.3390/ijms232012169] [Reference Citation Analysis]
12 Zhou Z, Wang C, Bai J, Zeng Z, Yang X, Wei B, Yang Z. Cinnamaldehyde-modified chitosan hybrid nanoparticles for DOX delivering to produce synergistic anti-tumor effects. Front Bioeng Biotechnol 2022;10:968065. [DOI: 10.3389/fbioe.2022.968065] [Reference Citation Analysis]
13 Liu P, Fan D, Qiao W, He X, Zhang L, Jiang Y, Yang T. SAR Study and Molecular Mechanism Investigation of Novel Naphthoquinone-furan-2-cyanoacryloyl Hybrids with Antitumor Activity. Pharmaceutics 2022;14:2104. [PMID: 36297539 DOI: 10.3390/pharmaceutics14102104] [Reference Citation Analysis]
14 Luo F, Zhao J, Liu S, Xue Y, Tang D, Yang J, Mei Y, Li G, Xie Y. Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction. Biochem Pharmacol 2022;:115278. [PMID: 36191625 DOI: 10.1016/j.bcp.2022.115278] [Reference Citation Analysis]
15 Lendeckel U, Wolke C. Redox-Regulation in Cancer Stem Cells. Biomedicines 2022;10:2413. [DOI: 10.3390/biomedicines10102413] [Reference Citation Analysis]
16 Lu S, Li Y, Zhu C, Wang W, Zhou Y, Natarajan N. Managing Cancer Drug Resistance from the Perspective of Inflammation. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/3426407] [Reference Citation Analysis]
17 Brockmueller A, Mueller A, Kunnumakkara AB, Aggarwal BB, Shakibaei M. Multifunctionality of Calebin A in inflammation, chronic diseases and cancer. Front Oncol 2022;12:962066. [DOI: 10.3389/fonc.2022.962066] [Reference Citation Analysis]
18 Qi L, Wang Y, Su S, Wang M, Jablonska E, Jia Y, Wang R, Hao S, Feng C, Li G, Jiang M, Du L, Sun H, Li Q, Wang T. Sodium selenite inhibits cervical cancer growth via ROS mediated AMPK/FOXO3a /GADD45a axis. Chem Biol Interact 2022;367:110171. [PMID: 36108716 DOI: 10.1016/j.cbi.2022.110171] [Reference Citation Analysis]
19 Gabr SA, Elsaed WM, Eladl MA, El-sherbiny M, Ebrahim HA, Asseri SM, Eltahir YAM, Elsherbiny N, Eldesoqui M. Curcumin Modulates Oxidative Stress, Fibrosis, and Apoptosis in Drug-Resistant Cancer Cell Lines. Life 2022;12:1427. [DOI: 10.3390/life12091427] [Reference Citation Analysis]
20 Zhang M, Yang C, Ruan X, Liu X, Wang D, Liu L, Shao L, Wang P, Dong W, Xue Y. CPEB2 m6A methylation regulates blood-tumor barrier permeability by regulating splicing factor SRSF5 stability. Commun Biol 2022;5:908. [PMID: 36064747 DOI: 10.1038/s42003-022-03878-9] [Reference Citation Analysis]
21 Mossenta M, Busato D, Dal Bo M, Macor P, Toffoli G. Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies. Int J Mol Sci 2022;23:10038. [PMID: 36077433 DOI: 10.3390/ijms231710038] [Reference Citation Analysis]
22 Eptaminitaki GC, Stellas D, Bonavida B, Baritaki S. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Drug Resistance Updates 2022;65:100866. [DOI: 10.1016/j.drup.2022.100866] [Reference Citation Analysis]
23 Beteta-göbel R, Miralles M, Fernández-díaz J, Rodríguez-lorca R, Torres M, Fernández-garcía P, Escribá PV, Lladó V. HCA (2-Hydroxy-Docosahexaenoic Acid) Induces Apoptosis and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells. IJMS 2022;23:9902. [DOI: 10.3390/ijms23179902] [Reference Citation Analysis]
24 Li C, Wu X, Zheng C, Xu S, Liu Y, Qin J, Fan X, Ye Y, Fei W. Nanotechnology-integrated ferroptosis inducers: a sharp sword against tumor drug resistance. J Mater Chem B 2022. [PMID: 36043505 DOI: 10.1039/d2tb01350a] [Reference Citation Analysis]
25 Du T, Shi Z, Qin Z, Hu Y, Zhu Y, Jiang H, Wang X. Tailoring Photothermally Triggered Phase Transition of Multimodal Cascade Theranostics Platform by Spherical Nucleic Acids. Adv Funct Materials. [DOI: 10.1002/adfm.202207410] [Reference Citation Analysis]
26 Li JJ, Xia XP, Wu LM, Zhu Z, Shi YN, Zhang XC, Xia YS, Lu GR. Cancer suppression by ferroptosis and its role in digestive system tumors. Shijie Huaren Xiaohua Zazhi 2022; 30(16): 718-728 [DOI: 10.11569/wcjd.v30.i16.718] [Reference Citation Analysis]
27 Zhu H, Qu Y, Wang S, Huang J, Zhu J, Wang L, Cai K, Zhang J. Melanin Nanoparticle-Actuated Redox-State Perturbation and Temporally Photoactivated Thermal Stress for Synergistic Tumor Therapy. ACS Biomater Sci Eng 2022. [PMID: 36001109 DOI: 10.1021/acsbiomaterials.2c00614] [Reference Citation Analysis]
28 Navas LE, Carnero A. Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer. Cells 2022;11:2627. [DOI: 10.3390/cells11172627] [Reference Citation Analysis]
29 Marei HE. Multimodal targeting of glioma with functionalized nanoparticles. Cancer Cell Int 2022;22:265. [PMID: 35999629 DOI: 10.1186/s12935-022-02687-8] [Reference Citation Analysis]
30 Wang Z, Wu S, Zhu C, Shen J. The role of ferroptosis in esophageal cancer. Cancer Cell Int 2022;22:266. [PMID: 35999642 DOI: 10.1186/s12935-022-02685-w] [Reference Citation Analysis]
31 Liu H, Wang D, Kan S, Hao M, Chang L, Lu P, Liu Y, Jin Y, Liu W. The role of lncRNAs and XIST in oral cancer. Front Cell Dev Biol 2022;10:826650. [DOI: 10.3389/fcell.2022.826650] [Reference Citation Analysis]
32 Kwak A, Park JW, Lee S, Lee J, Seo J, Yoon G, Lee M, Choi J, Shim J. Isolinderalactone sensitizes oxaliplatin-resistance colorectal cancer cells through JNK/p38 MAPK signaling pathways. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154383] [Reference Citation Analysis]
33 Chen Q, Jia C, Xu Y, Jiang Z, Hu T, Li C, Cheng X. Dual-pH responsive chitosan nanoparticles for improving in vivo drugs delivery and chemoresistance in breast cancer. Carbohydrate Polymers 2022;290:119518. [DOI: 10.1016/j.carbpol.2022.119518] [Reference Citation Analysis]
34 Bär SI, Biersack B, Schobert R. 3D cell cultures, as a surrogate for animal models, enhance the diagnostic value of preclinical in vitro investigations by adding information on the tumour microenvironment: a comparative study of new dual-mode HDAC inhibitors. Invest New Drugs 2022. [PMID: 35796910 DOI: 10.1007/s10637-022-01280-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Singh D, Assaraf YG, Gacche RN. Long Non-coding RNA Mediated Drug Resistance in Breast Cancer. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Dunsmore L, Navo CD, Becher J, de Montes EG, Guerreiro A, Hoyt E, Brown L, Zelenay V, Mikutis S, Cooper J, Barbieri I, Lawrinowitz S, Siouve E, Martin E, Ruivo PR, Rodrigues T, da Cruz FP, Werz O, Vassiliou G, Ravn P, Jiménez-Osés G, Bernardes GJL. Controlled masking and targeted release of redox-cycling ortho-quinones via a C-C bond-cleaving 1,6-elimination. Nat Chem 2022;14:754-65. [PMID: 35764792 DOI: 10.1038/s41557-022-00964-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Domínguez-álvarez E, Rácz B, Marć MA, Nasim MJ, Szemerédi N, Viktorová J, Jacob C, Spengler G. Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents. Drug Resistance Updates 2022;63:100844. [DOI: 10.1016/j.drup.2022.100844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Betlej G, Ząbek T, Lewińska A, Błoniarz D, Rzeszutek I, Wnuk M. RNA 5-methylcytosine status is associated with DNMT2/TRDMT1 nuclear localization in osteosarcoma cell lines. Journal of Bone Oncology 2022. [DOI: 10.1016/j.jbo.2022.100448] [Reference Citation Analysis]
39 Mostafa S, El-bolok AHM, Fahmi AN, Alaaeldin E. An Ex vivo Apoptotic and Cytotoxic Effects of Frankincense on Oral Squamous Cell Carcinoma Cell Line. Open Access Maced J Med Sci 2022;10:281-290. [DOI: 10.3889/oamjms.2022.9979] [Reference Citation Analysis]
40 Romo-González M, Ijurko C, Hernández-Hernández Á. Reactive Oxygen Species and Metabolism in Leukemia: A Dangerous Liaison. Front Immunol 2022;13:889875. [PMID: 35757686 DOI: 10.3389/fimmu.2022.889875] [Reference Citation Analysis]
41 Tomorowicz Ł, Żołnowska B, Szafrański K, Chojnacki J, Konopiński R, Grzybowska EA, Sławiński J, Kawiak A. New 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-N-(imidazolidin-2-ylidene)-4-chloro-5-methylbenzenesulfonamide Derivatives, Design, Synthesis and Anticancer Evaluation. IJMS 2022;23:7178. [DOI: 10.3390/ijms23137178] [Reference Citation Analysis]
42 Yu W, Tu Y, Long Z, Liu J, Kong D, Peng J, Wu H, Zheng G, Zhao J, Chen Y, Liu R, Li W, Hai C, Zhou J. Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/2606928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Qin S, Li B, Ming H, Nice EC, Zou B, Huang C. Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy. Biochim Biophys Acta Rev Cancer 2022;1877:188749. [PMID: 35716972 DOI: 10.1016/j.bbcan.2022.188749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Hao W, Li M, Cai Q, Wu S, Li X, He Q, Hu Y. Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches. Front Physiol 2022;13:889792. [DOI: 10.3389/fphys.2022.889792] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zhang S, Li Y, Liu C, Zhang Y, Sun P, Lan X, Liu C. Supramolecular amino acid-based metallo-nanozyme through multicomponent coordination self-assembly for in-site tumor synergistic catalytic-chemotherapy. Chemical Engineering Journal 2022;437:135312. [DOI: 10.1016/j.cej.2022.135312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Lai JW, Maah MJ, Sarip R, Lim YAL, Tim KL, Ng CH. Potency of copper(II) complexes towards drug-sensitive and -resistant Plasmodium falciparum: structure-activity relationship, ROS-generation and proteasome inhibition. Journal of Molecular Structure 2022. [DOI: 10.1016/j.molstruc.2022.133588] [Reference Citation Analysis]
47 Jovanović M, Podolski-renić A, Krasavin M, Pešić M. The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance. Front Mol Biosci 2022;9:883297. [DOI: 10.3389/fmolb.2022.883297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Jiang S, Li X, Zhang F, Mao J, Cao M, Zhang X, Huang S, Duan X, Shen J. Manganese Dioxide-Based Nanocarrier Delivers Paclitaxel to Enhance Chemotherapy against Orthotopic Glioma through Hypoxia Relief. Small Methods 2022;:e2101531. [PMID: 35587180 DOI: 10.1002/smtd.202101531] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Xie W, Ye J, Guo Z, Lu J, Gao X, Wei Y, Zhao L. Ultrafast Fabrication of Iron/Manganese Co-Doped Bismuth Trimetallic Nanoparticles: A Thermally Aided Chemodynamic/Radio-Nanoplatform for Low-Dose Radioresistance. ACS Appl Mater Interfaces 2022;14:21931-44. [PMID: 35511491 DOI: 10.1021/acsami.2c02484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Liu M, Xu C, Qin X, Liu W, Li D, Jia H, Gao X, Wu Y, Wu Q, Xu X, Xing B, Jiang X, Lu H, Zhang Y, Ding H, Zhao Q. DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer. Front Oncol 2022;12:873649. [DOI: 10.3389/fonc.2022.873649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Matou-nasri S, Najdi M, Alsaud NA, Alhaidan Y, Al-eidi H, Alatar G, Alwadaani D, Trivilegio T, Alsubait A, Altuwaijri A, Abudawood M, Almuzzaini B. Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on miRNA profiling. PLoS ONE 2022;17:e0267855. [DOI: 10.1371/journal.pone.0267855] [Reference Citation Analysis]
52 de Souza Pessoa A, Tokuhara CK, Fakhoury VS, Pagnan AL, Neubern de Oliveira GS, Rovis Sanches ML, Inacio KK, Costa BC, Ximenes VF, Oliveira RC. The dimerization of methyl vanillate improves its effect against breast cancer cells via pro-oxidant effect. Chem Biol Interact 2022;:109962. [PMID: 35523312 DOI: 10.1016/j.cbi.2022.109962] [Reference Citation Analysis]
53 Zhang Y, Wang M, Meng F, Yang M, Chen Y, Guo X, Wang W, Zhu Y, Guo Y, Feng C, Tian S, Zhang H, Li H, Sun J, Wang W. A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis. Cell Death Discov 2022;8:238. [PMID: 35501301 DOI: 10.1038/s41420-022-01039-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Niapour A, Seyedasli N. Acquisition of paclitaxel resistance modulates the biological traits of gastric cancer AGS cells and facilitates epithelial to mesenchymal transition and angiogenesis. Naunyn Schmiedebergs Arch Pharmacol 2022;395:515-33. [PMID: 35122114 DOI: 10.1007/s00210-022-02217-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
55 Chen D, Wei X, Yang K, Liu X, Song Y, Bai F, Jiang Y, Guo Y, Jha RK. Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS-STAT3 pathway. J Int Med Res 2022;50:3000605221093308. [PMID: 35481419 DOI: 10.1177/03000605221093308] [Reference Citation Analysis]
56 Cui Q, Liang XL, Wang JQ, Zhang JY, Chen ZS. Therapeutic implication of carbon monoxide in drug resistant cancers. Biochem Pharmacol 2022;:115061. [PMID: 35489394 DOI: 10.1016/j.bcp.2022.115061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Zhao Y, Yang Y, Sheng H, Tang Q, Han L, Wang S, Wu W. GPX4 Plays a Crucial Role in Fuzheng Kang’ai Decoction-Induced Non-Small Cell Lung Cancer Cell Ferroptosis. Front Pharmacol 2022;13:851680. [DOI: 10.3389/fphar.2022.851680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
58 Maiuolo J, Musolino V, Gliozzi M, Carresi C, Oppedisano F, Nucera S, Scarano F, Scicchitano M, Guarnieri L, Bosco F, Macrì R, Ruga S, Cardamone A, Coppoletta AR, Ilari S, Mollace A, Muscoli C, Cognetti F, Mollace V. The Employment of Genera Vaccinium, Citrus, Olea, and Cynara Polyphenols for the Reduction of Selected Anti-Cancer Drug Side Effects. Nutrients 2022;14:1574. [DOI: 10.3390/nu14081574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Zuo J, Zhang Z, Luo M, Zhou L, Nice EC, Zhang W, Wang C, Huang C. Redox signaling at the crossroads of human health and disease. MedComm 2022;3. [DOI: 10.1002/mco2.127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
60 Fu H, Wu ZX, Lei ZN, Teng QX, Yang Y, Ashby CR, Lei Y, Lian Y, Chen ZS. The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter. Front Pharmacol 2022;13:861642. [PMID: 35350768 DOI: 10.3389/fphar.2022.861642] [Reference Citation Analysis]
61 Xu X, Wang C, Zhang P, Gao X, Guan W, Wang F, Li X, Yuan J, Dou H, Xu G. Enhanced Intracellular Reactive Oxygen Species by Photodynamic Therapy Effectively Promotes Chemoresistant Cell Death. Int J Biol Sci 2022;18:374-85. [PMID: 34975339 DOI: 10.7150/ijbs.66602] [Reference Citation Analysis]
62 Chen J, Ruijtenbeek R, Garssen J, Redegeld FA. Esterified derivatives of DHA and EPA increase bortezomib cytotoxicity in human multiple myeloma cells. Eur J Pharmacol 2022;:174883. [PMID: 35341783 DOI: 10.1016/j.ejphar.2022.174883] [Reference Citation Analysis]
63 Cen K, Chen M, He M, Li Z, Song Y, Liu P, Jiang Q, Xu S, Jia Y, Shen P. Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity. Front Pharmacol 2022;13:826716. [PMID: 35264959 DOI: 10.3389/fphar.2022.826716] [Reference Citation Analysis]
64 Tan W, Zhang K, Chen X, Yang L, Zhu S, Wei Y, Xie Z, Chen Y, Shang C. GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma. Journal of Advanced Research 2022. [DOI: 10.1016/j.jare.2022.03.012] [Reference Citation Analysis]
65 Lin J, Hu P, Wang Y, Tan Y, Yu K, Liao K, Wu Q, Li T, Meng Q, Lin J, Liu Z, Pu H, Ju H, Xu R, Qiu M. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Sig Transduct Target Ther 2022;7. [DOI: 10.1038/s41392-022-00889-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
66 Wang H, Ju J, Wang S, Zhang Y, Liu C, Wang T, Yu X, Wang F, Cheng X, Wang K, Chen Z. Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer. Front Oncol 2022;12:812534. [DOI: 10.3389/fonc.2022.812534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Xu P, Zhang S, Tan L, Wang L, Yang Z, Li J. Local Anesthetic Ropivacaine Exhibits Therapeutic Effects in Cancers. Front Oncol 2022;12:836882. [PMID: 35186766 DOI: 10.3389/fonc.2022.836882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
68 Liu J, Yuan Y, Cheng Y, Fu D, Chen Z, Wang Y, Zhang L, Yao C, Shi L, Li M, Zhou C, Zou M, Wang G, Wang L, Wang Z. Copper-Based Metal-Organic Framework Overcomes Cancer Chemoresistance through Systemically Disrupting Dynamically Balanced Cellular Redox Homeostasis. J Am Chem Soc 2022. [PMID: 35192770 DOI: 10.1021/jacs.1c11856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
69 Yin H, Jin Z, Duan W, Han B, Han L, Li C. Emergence of Responsive Surface-Enhanced Raman Scattering Probes for Imaging Tumor-Associated Metabolites. Adv Healthc Mater 2022;:e2200030. [PMID: 35182455 DOI: 10.1002/adhm.202200030] [Reference Citation Analysis]
70 Gao M, Yang Y, Gao Y, Liu T, Guan Q, Zhou T, Shi Y, Hao M, Li Z, Zuo D, Zhang W, Wu Y. The anti-MDR efficacy of YAN against A549/Taxol cells is associated with its inhibition on glycolysis and is further enhanced by 2-deoxy-D-glucose. Chem Biol Interact 2022;:109843. [PMID: 35122754 DOI: 10.1016/j.cbi.2022.109843] [Reference Citation Analysis]
71 Long W, Zhang L, Wang Y, Xie H, Wang L, Yu H, Zheng D. Research Progress and Prospects of Autophagy in the Mechanism of Multidrug Resistance in Tumors. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/7032614] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
72 Zhao Q, Yuan X, Zheng L, Xue M. miR-30d-5p: A Non-Coding RNA With Potential Diagnostic, Prognostic and Therapeutic Applications. Front Cell Dev Biol 2022;10:829435. [DOI: 10.3389/fcell.2022.829435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Zuo J, Zhang Z, Li M, Yang Y, Zheng B, Wang P, Huang C, Zhou S. The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role. Mol Cancer 2022;21:30. [PMID: 35081965 DOI: 10.1186/s12943-021-01488-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
74 Catalano A, Iacopetta D, Ceramella J, Scumaci D, Giuzio F, Saturnino C, Aquaro S, Rosano C, Sinicropi MS. Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies. Molecules 2022;27:616. [PMID: 35163878 DOI: 10.3390/molecules27030616] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 22.0] [Reference Citation Analysis]
75 Liu Z, Li Y, Zhu Y, Li N, Li W, Shang C, Song G, Li S, Cong J, Li T, Xiu Z, Lu J, Ge C, Yang X, Li Y, Sun L, Li X, Jin N. Apoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway. Int J Biol Sci 2022;18:717-30. [PMID: 35002520 DOI: 10.7150/ijbs.64350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
76 Shen J, Sun C, Liu Q, Kai G, Qian J. Nano Drug Delivery Systems: Effective Therapy Strategies to Overcome Multidrug Resistance in Tumor Cells. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202104321] [Reference Citation Analysis]
77 Yang Z, Yang A, Ma W, Ma K, Lv YK, Peng P, Zang SQ, Li B. Atom-precise fluorescent copper cluster for tumor microenvironment targeting and transient chemodynamic cancer therapy. J Nanobiotechnology 2022;20:20. [PMID: 34991596 DOI: 10.1186/s12951-021-01207-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Gautam A, Goyal L. Role of ROS in Combined Radiation Effect in Cancer Therapy. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_65-1] [Reference Citation Analysis]
79 Mozafari F, Rashidzadeh H, Ghaffarlou M, Salehiabar M, Ertas YN, Ramazani A, Abazari M, Rahmati M, Javed Y, Sharma SK, Danafar H. ROS-Based Cancer Radiotherapy. Harnessing Materials for X-ray Based Cancer Therapy and Imaging 2022. [DOI: 10.1007/978-3-031-04071-9_10] [Reference Citation Analysis]
80 Gautam A, Goyal L. Role of ROS in Combined Radiation Effect in Cancer Therapy. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_65] [Reference Citation Analysis]
81 Nasrin T, Chakraborti S, Shaikh S. Reactive Species and ER-Mitochondrial Performance for Glioblastoma Multiforme Treatment Strategy. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects 2022. [DOI: 10.1007/978-981-15-9411-3_20] [Reference Citation Analysis]
82 Wu Z, Wang J, Cui Q, Xu X, Chen Z. Paclitaxel and chemoresistance. Paclitaxel 2022. [DOI: 10.1016/b978-0-323-90951-8.00002-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Ferrer RE, Ong MC, Jacinto S. Extract of Codiaeum luzonicum Merr. overcomes multidrug resistance in human colon cancer cells by modulating P-glycoprotein. Asian Pac J Trop Biomed 2022;12:400. [DOI: 10.4103/2221-1691.354431] [Reference Citation Analysis]
84 Cui Q, Wang J, Yang D, Chen Z. Therapeutic Implication of Oxidative Stress Regulators in Drug-Resistant Cancers. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_157] [Reference Citation Analysis]
85 Cui Q, Wang J, Yang D, Chen Z. Therapeutic Implication of Oxidative Stress Regulators in Drug-Resistant Cancers. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_157-1] [Reference Citation Analysis]
86 Xing Y, Wang L, Wang L, Huang J, Wang S, Xie X, Zhu J, Ding T, Cai K, Zhang J. Flower‐Like Nanozymes with Large Accessibility of Single Atom Catalysis Sites for ROS Generation Boosted Tumor Therapy. Adv Funct Materials 2022;32:2111171. [DOI: 10.1002/adfm.202111171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
87 Cohen L, Assaraf YG, Livney YD. Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment. Pharmaceutics 2021;14:88. [PMID: 35056984 DOI: 10.3390/pharmaceutics14010088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
88 Feng X, Jiang T, Yang C, Pang S, Ding Z, Hu H, Wang H, Dong L, Yang N. RPRD1A stabilizes NRF2 and aggravates HCC progression through competing with p62 for TRIM21 binding. Cell Death Dis 2021;13:6. [PMID: 34921137 DOI: 10.1038/s41419-021-04447-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
89 Tang Z, Huang Z, Huang Y, Chen Y, Huang M, Liu H, Ye QA, Zhao J, Jia B. Ferroptosis: The Silver Lining of Cancer Therapy. Front Cell Dev Biol 2021;9:765859. [PMID: 34912804 DOI: 10.3389/fcell.2021.765859] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
90 Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat 2021;:100797. [PMID: 34955385 DOI: 10.1016/j.drup.2021.100797] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
91 Sun Y, Liu X, Wang L, Xu L, Liu K, Xu L, Shi F, Zhang Y, Gu N, Xiong F. High-performance SOD mimetic enzyme Au@Ce for arresting cell cycle and proliferation of acute myeloid leukemia. Bioact Mater 2022;10:117-30. [PMID: 34901534 DOI: 10.1016/j.bioactmat.2021.08.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
92 Yu T, Huang D, Wu H, Chen H, Chen S, Cui Q. Navigating Calcium and Reactive Oxygen Species by Natural Flavones for the Treatment of Heart Failure. Front Pharmacol 2021;12:718496. [PMID: 34858167 DOI: 10.3389/fphar.2021.718496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Lu X, Wu M, Wang S, Qin J, Li P. Development of a NIR fluorescent probe for the detection of intracellular cysteine and glutathione and the monitoring of the drug resistance. Talanta 2021;235:122771. [PMID: 34517629 DOI: 10.1016/j.talanta.2021.122771] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
94 Huang A, Zeng P, Li Y, Lu W, Lai Y. LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway. Front Oncol 2021;11:782065. [PMID: 34820336 DOI: 10.3389/fonc.2021.782065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
95 Chen L, Wang J, Cai X, Chen S, Zhang J, Li B, Chen W, Guo X, Luo H, Chen J. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway. Bioorg Chem 2021;119:105516. [PMID: 34856444 DOI: 10.1016/j.bioorg.2021.105516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
96 Yalcin-Ozkat G. Molecular Modeling Strategies of Cancer Multidrug Resistance. Drug Resist Updat 2021;:100789. [PMID: 34973929 DOI: 10.1016/j.drup.2021.100789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
97 Qi X, Li S, Song X, Gong Y, Guo Z, Cui C, Wang X, Tan Z. An Fe‐MIL100 Based Drug Delivery System for pH and Glutathione Dual‐Responsive Drug Release. ChemistrySelect 2021;6:12295-9. [DOI: 10.1002/slct.202103551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Xu JH, Guan YJ, Qiu ZD, Zhang X, Zi LL, Zhou Y, Chen C, Yu J, Zhang YC, Wang WX. System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma. Oxid Med Cell Longev 2021;2021:6485871. [PMID: 34795841 DOI: 10.1155/2021/6485871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
99 Zhao R, Ning X, Wang M, Yu A, Wang Y. A multifunctional nano-delivery system enhances the chemo-co-phototherapy of tumor multidrug resistance via mitochondrial-targeting and inhibiting P-glycoprotein-mediated efflux. J Mater Chem B 2021;9:9174-82. [PMID: 34698329 DOI: 10.1039/d1tb01658j] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
100 Wang JQ, Cui Q, Lei ZN, Teng QX, Ji N, Lin L, Liu Z, Chen ZS. Insights on the structure-function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies. MedComm (2020) 2021;2:221-35. [PMID: 34766143 DOI: 10.1002/mco2.65] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
101 Zhang H, Han X, Wang Z, Wang Z, Cui Y, Tian R, Zhu Y, Han B, Liu H, Zuo X, Ren S, Tian J, Niu R, Zhang F. Mitochondrial Breast Cancer Resistant Protein Sustains the Proliferation and Survival of Drug-Resistant Breast Cancer Cells by Regulating Intracellular Reactive Oxygen Species. Front Cell Dev Biol 2021;9:719209. [PMID: 34650973 DOI: 10.3389/fcell.2021.719209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
102 Wang JQ, Wu ZX, Yang Y, Li JS, Yang DH, Fan YF, Chen ZS. Establishment and Characterization of a Novel Multidrug Resistant Human Ovarian Cancer Cell Line With Heterogenous MRP7 Overexpression. Front Oncol 2021;11:731260. [PMID: 34631561 DOI: 10.3389/fonc.2021.731260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 Esfahani MKM, Alavi SE, Cabot PJ, Islam N, Izake EL. PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells. Pharmaceutics 2021;13:1605. [PMID: 34683898 DOI: 10.3390/pharmaceutics13101605] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
104 Zhang SX, Liu W, Ai B, Sun LL, Chen ZS, Lin LZ. Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review. Recent Pat Anticancer Drug Discov 2021. [PMID: 34587888 DOI: 10.2174/1574892816666210929165729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
105 Shah MA, Rogoff HA. Implications of reactive oxygen species on cancer formation and its treatment. Semin Oncol 2021;48:238-45. [PMID: 34548190 DOI: 10.1053/j.seminoncol.2021.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
106 Wang J, Sun D, Huang L, Wang S, Jin Y. Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy. Oxid Med Cell Longev 2021;2021:8532940. [PMID: 34539975 DOI: 10.1155/2021/8532940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
107 Zhou X, Wang F, Wu H, Chen X, Zhang Y, Lin J, Cai Y, Xiang J, He N, Hu Z, Jin X. Thymoquinone Suppresses the Proliferation, Migration and Invasiveness through Regulating ROS, Autophagic Flux and miR-877-5p in Human Bladder Carcinoma Cells. Int J Biol Sci 2021;17:3456-75. [PMID: 34512159 DOI: 10.7150/ijbs.60401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
108 Nwahara N, Abrahams G, Prinsloo E, Nyokong T. Folic acid-modified phthalocyanine-nanozyme loaded liposomes for targeted photodynamic therapy. Photodiagnosis Photodyn Ther 2021;36:102527. [PMID: 34517120 DOI: 10.1016/j.pdpdt.2021.102527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Hung SY, Chen WF, Lee YC, Su JH, Juan YS, Lin IP, Zhang YH, Chang MK, Lin MY, Chen CY, Lee CH. Rhopaloic acid A induces apoptosis, autophagy and MAPK activation through ROS-mediated signaling in bladder cancer. Phytomedicine 2021;92:153720. [PMID: 34481340 DOI: 10.1016/j.phymed.2021.153720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
110 Su Z, Dong S, Zhao SC, Liu K, Tan Y, Jiang X, Assaraf YG, Qin B, Chen ZS, Zou C. Novel nanomedicines to overcome cancer multidrug resistance. Drug Resist Updat 2021;58:100777. [PMID: 34481195 DOI: 10.1016/j.drup.2021.100777] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 27.0] [Reference Citation Analysis]
111 Pordel S, Pickens RN, White JK. Release of CO and Production of 1 O 2 from a Mn-BODIPY Photoactivated CO Releasing Molecule with Visible Light. Organometallics 2021;40:2983-94. [DOI: 10.1021/acs.organomet.1c00331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
112 Wang JQ, Wu ZX, Yang Y, Teng QX, Li YD, Lei ZN, Jani KA, Kaushal N, Chen ZS. ATP-binding cassette (ABC) transporters in cancer: A review of recent updates. J Evid Based Med 2021. [PMID: 34388310 DOI: 10.1111/jebm.12434] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
113 Valente A, Podolski-Renić A, Poetsch I, Filipović N, López Ó, Turel I, Heffeter P. Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance. Drug Resist Updat 2021;58:100778. [PMID: 34403910 DOI: 10.1016/j.drup.2021.100778] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
114 Liang W, He X, Bi J, Hu T, Sun Y. Role of reactive oxygen species in tumors based on the 'seed and soil' theory: A complex interaction (Review). Oncol Rep 2021;46:208. [PMID: 34328200 DOI: 10.3892/or.2021.8159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
115 Sumkhemthong S, Prompetchara E, Chanvorachote P, Chaotham C. Cisplatin-induced hydroxyl radicals mediate pro-survival autophagy in human lung cancer H460 cells. Biol Res 2021;54:22. [PMID: 34321115 DOI: 10.1186/s40659-021-00346-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
116 Azevedo A, Farinha D, Geraldes C, Faneca H. Combining gene therapy with other therapeutic strategies and imaging agents for cancer theranostics. Int J Pharm 2021;606:120905. [PMID: 34293466 DOI: 10.1016/j.ijpharm.2021.120905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
117 Liang L, Peng Y, Qiu L. Mitochondria-targeted vitamin E succinate delivery for reversal of multidrug resistance. J Control Release 2021;337:117-31. [PMID: 34274383 DOI: 10.1016/j.jconrel.2021.07.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
118 Cauli O. Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review. Antioxidants (Basel) 2021;10:1116. [PMID: 34356349 DOI: 10.3390/antiox10071116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
119 Zong Q, Wang K, Xiao X, Jiang M, Li J, Yuan Y, Wang J. Amplification of tumor oxidative stresses by Poly(disulfide acetal) for multidrug resistance reversal. Biomaterials 2021;276:121005. [PMID: 34252801 DOI: 10.1016/j.biomaterials.2021.121005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
120 Demircan Yalçın Y, Töral TB, Sukas S, Yıldırım E, Zorlu Ö, Gündüz U, Külah H. A microfluidic device enabling drug resistance analysis of leukemia cells via coupled dielectrophoretic detection and impedimetric counting. Sci Rep 2021;11:13193. [PMID: 34162990 DOI: 10.1038/s41598-021-92647-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Xu J, Xu Y, Sun L, Lu B, Yan X, Wang Z, Zhang T. Glucose oxidase loaded Cu2+ based metal-organic framework for glutathione depletion/reactive oxygen species elevation enhanced chemotherapy. Biomed Pharmacother 2021;141:111606. [PMID: 34153849 DOI: 10.1016/j.biopha.2021.111606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
122 You KS, Yi YW, Cho J, Park JS, Seong YS. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer. Pharmaceuticals (Basel) 2021;14:589. [PMID: 34207383 DOI: 10.3390/ph14060589] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
123 Xi L, Wang J, Wang Y, Ge Z. Dual-Targeting Polymeric Nanocarriers to Deliver ROS-Responsive Prodrugs and Combat Multidrug Resistance of Cancer Cells. Macromol Biosci 2021;:e2100091. [PMID: 34145971 DOI: 10.1002/mabi.202100091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
124 Comert F, Heinrich F, Chowdhury A, Schoeneck M, Darling C, Anderson KW, Libardo MDJ, Angeles-Boza AM, Silin V, Cotten ML, Mihailescu M. Copper-binding anticancer peptides from the piscidin family: an expanded mechanism that encompasses physical and chemical bilayer disruption. Sci Rep 2021;11:12620. [PMID: 34135370 DOI: 10.1038/s41598-021-91670-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
125 Chao WW, Liou YJ, Ma HT, Chen YH, Chou ST. Phytochemical composition and bioactive effects of ethyl acetate fraction extract (EAFE) of Glechoma hederacea L. J Food Biochem 2021;45:e13815. [PMID: 34121206 DOI: 10.1111/jfbc.13815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
126 Totten SP, Im YK, Cepeda Cañedo E, Najyb O, Nguyen A, Hébert S, Ahn R, Lewis K, Lebeau B, La Selva R, Sabourin V, Martínez C, Savage P, Kuasne H, Avizonis D, Santos Martínez N, Chabot C, Aguilar-Mahecha A, Goulet ML, Dankner M, Witcher M, Petrecca K, Basik M, Pollak M, Topisirovic I, Lin R, Siegel PM, Kleinman CL, Park M, St-Pierre J, Ursini-Siegel J. STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer. Nat Commun 2021;12:3299. [PMID: 34083537 DOI: 10.1038/s41467-021-23396-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
127 Feng W, Wang L, Gao J, Zhao M, Li Y, Wu Z, Yan C. Solid state and solubility study of a potential anticancer drug-drug molecular salt of diclofenac and metformin. Journal of Molecular Structure 2021;1234:130166. [DOI: 10.1016/j.molstruc.2021.130166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
128 Esfahani MKM, Islam N, Cabot PJ, Izake EL. Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy. ACS Biomater Sci Eng 2021. [PMID: 34056895 DOI: 10.1021/acsbiomaterials.1c00066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
129 Chen JB, Kong XF, Mu F, Lu TY, Lu YY, Xu KC. Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer. Med Gas Res 2020;10:75-80. [PMID: 32541132 DOI: 10.4103/2045-9912.285560] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
130 Czarnomysy R, Muszyńska A, Rok J, Rzepka Z, Bielawski K. Mechanism of Anticancer Action of Novel Imidazole Platinum(II) Complex Conjugated with G2 PAMAM-OH Dendrimer in Breast Cancer Cells. Int J Mol Sci 2021;22:5581. [PMID: 34070401 DOI: 10.3390/ijms22115581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 He Z, Tian S, Gao Y, Meng F, Luo L. Luminescent AIE Dots for Anticancer Photodynamic Therapy. Front Chem 2021;9:672917. [PMID: 34113602 DOI: 10.3389/fchem.2021.672917] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
132 Yan X, Lin W, Liu H, Pu W, Li J, Wu P, Ding J, Luo G, Zhang J. Wavelength-Tunable, Long Lifetime, and Biocompatible Luminescent Nanoparticles Based on a Vitamin E-Derived Material for Inflammation and Tumor Imaging. Small 2021;17:e2100045. [PMID: 34031977 DOI: 10.1002/smll.202100045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
133 Zhou C, Wang Z, Li J, Wu X, Fan N, Li D, Liu F, Plum PS, Hoppe S, Hillmer AM, Quaas A, Gebauer F, Chon SH, Bruns CJ, Zhao Y. Aldo-Keto Reductase 1C3 Mediates Chemotherapy Resistance in Esophageal Adenocarcinoma via ROS Detoxification. Cancers (Basel) 2021;13:2403. [PMID: 34065695 DOI: 10.3390/cancers13102403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
134 Cotoraci C, Ciceu A, Sasu A, Miutescu E, Hermenean A. Bioactive Compounds from Herbal Medicine Targeting Multiple Myeloma. Applied Sciences 2021;11:4451. [DOI: 10.3390/app11104451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Shi L, Gao LL, Cai SZ, Xiong QW, Ma ZR. A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells. Eur J Med Chem 2021;221:113528. [PMID: 34020339 DOI: 10.1016/j.ejmech.2021.113528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
136 Liu S, Khan AR, Yang X, Dong B, Ji J, Zhai G. The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy. J Control Release 2021;335:1-20. [PMID: 33991600 DOI: 10.1016/j.jconrel.2021.05.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
137 Li D, Peng W, Wu B, Liu H, Zhang R, Zhou R, Yao L, Ye L. Metallothionein MT1M Suppresses Carcinogenesis of Esophageal Carcinoma Cells through Inhibition of the Epithelial-Mesenchymal Transition and the SOD1/PI3K Axis. Mol Cells 2021;44:267-78. [PMID: 33820882 DOI: 10.14348/molcells.2021.2179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
138 Li L, Qiu C, Hou M, Wang X, Huang C, Zou J, Liu T, Qu J. Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy. Front Oncol 2021;11:665945. [PMID: 33996593 DOI: 10.3389/fonc.2021.665945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
139 Liang X, Wang P, Yang C, Huang F, Wu H, Shi H, Wu X. Galangin Inhibits Gastric Cancer Growth Through Enhancing STAT3 Mediated ROS Production. Front Pharmacol 2021;12:646628. [PMID: 33981228 DOI: 10.3389/fphar.2021.646628] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
140 Peng J, Liu Y, Zhang M, Liu F, Ma L, Yu CY, Wei H. One-pot fabrication of dual-redox sensitive, stabilized supramolecular nanocontainers for potential programmable drug release using a multifunctional cyclodextrin unit. J Control Release 2021;334:290-302. [PMID: 33905803 DOI: 10.1016/j.jconrel.2021.04.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
141 Kumar V, Vashishta M, Kong L, Wu X, Lu JJ, Guha C, Dwarakanath BS. The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies. Front Cell Dev Biol 2021;9:650772. [PMID: 33968932 DOI: 10.3389/fcell.2021.650772] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 23.0] [Reference Citation Analysis]
142 Chen J, Jin X, Shen Z, Mei Y, Zhu J, Zhang X, Liang G, Zheng X. H2O2 enhances the anticancer activity of TMPyP4 by ROS-mediated mitochondrial dysfunction and DNA damage. Med Oncol 2021;38:59. [PMID: 33880669 DOI: 10.1007/s12032-021-01505-x] [Reference Citation Analysis]
143 Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi SMR, Ranjbar A, SeyedSaleh S, Sharifzadeh SO, Khan H, Ashrafizadeh M, Zarrabi A, Ahn KS. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules 2021;26:2382. [PMID: 33921908 DOI: 10.3390/molecules26082382] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 30.0] [Reference Citation Analysis]
144 Chen S, Bu D, Zhu J, Yue T, Guo S, Wang X, Pan Y, Liu Y, Wang P. Endogenous hydrogen sulfide regulates xCT stability through persulfidation of OTUB1 at cysteine 91 in colon cancer cells. Neoplasia 2021;23:461-72. [PMID: 33878705 DOI: 10.1016/j.neo.2021.03.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
145 Sun Y, Qiao Y, Liu Y, Zhou J, Wang X, Zheng H, Xu Z, Zhang J, Zhou Y, Qian L, Zhang C, Lou H. ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance. Redox Biol 2021;43:101977. [PMID: 33905957 DOI: 10.1016/j.redox.2021.101977] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
146 Carrà G, Ermondi G, Riganti C, Righi L, Caron G, Menga A, Capelletto E, Maffeo B, Lingua MF, Fusella F, Volante M, Taulli R, Guerrasio A, Novello S, Brancaccio M, Piazza R, Morotti A. IκBα targeting promotes oxidative stress-dependent cell death. J Exp Clin Cancer Res 2021;40:136. [PMID: 33863364 DOI: 10.1186/s13046-021-01921-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
147 Wang T, Dong J, Yuan X, Wen H, Wu L, Liu J, Sui H, Deng W. A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression. Front Pharmacol 2021;12:653306. [PMID: 33927626 DOI: 10.3389/fphar.2021.653306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
148 Barrera G, Cucci MA, Grattarola M, Dianzani C, Muzio G, Pizzimenti S. Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role. Antioxidants (Basel) 2021;10:510. [PMID: 33805928 DOI: 10.3390/antiox10040510] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
149 Li R, Chen Z, Dai Z, Yu Y. Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance. Cancer Biol Med 2021:j. [PMID: 33755377 DOI: 10.20892/j.issn.2095-3941.2020.0328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
150 Cohen L, Livney YD, Assaraf YG. Targeted nanomedicine modalities for prostate cancer treatment. Drug Resist Updat 2021;56:100762. [PMID: 33857756 DOI: 10.1016/j.drup.2021.100762] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
151 Wang X, Gong Q, Song C, Fang J, Yang Y, Liang X, Huang X, Liu J. Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways. Toxicol Appl Pharmacol 2021;418:115484. [PMID: 33716044 DOI: 10.1016/j.taap.2021.115484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
152 Schiavello M, Gazzano E, Bergandi L, Silvagno F, Libener R, Riganti C, Aldieri E. Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma. Cancers (Basel) 2021;13:1138. [PMID: 33799965 DOI: 10.3390/cancers13051138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Stanković T, Ranđelović T, Dragoj M, Stojković Burić S, Fernández L, Ochoa I, Pérez-García VM, Pešić M. In vitro biomimetic models for glioblastoma-a promising tool for drug response studies. Drug Resist Updat 2021;55:100753. [PMID: 33667959 DOI: 10.1016/j.drup.2021.100753] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
154 Song L, Zhao F, Liu Y, Guo X, Wu C, Liu J. Effects of 8-Amino-Isocorydine, a Derivative of Isocorydine, on Gastric Carcinoma Cell Proliferation and Apoptosis. Curr Ther Res Clin Exp 2021;94:100624. [PMID: 34306264 DOI: 10.1016/j.curtheres.2021.100624] [Reference Citation Analysis]
155 Das T, Anand U, Pandey SK, Ashby CR Jr, Assaraf YG, Chen ZS, Dey A. Therapeutic strategies to overcome taxane resistance in cancer. Drug Resist Updat 2021;55:100754. [PMID: 33691261 DOI: 10.1016/j.drup.2021.100754] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 37.0] [Reference Citation Analysis]
156 An D, Yu X, Jiang L, Wang R, He P, Chen N, Guo X, Li X, Feng M. Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment. Molecules 2021;26:1280. [PMID: 33652957 DOI: 10.3390/molecules26051280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
157 He Z, Gao Y, Zhang H, Wang X, Meng F, Luo L, Tang BZ. Platinum-AIEgen coordination complex for imaging-guided annihilation of cisplatin-resistant cancer cells. Chem Commun (Camb) 2020;56:7785-8. [PMID: 32542273 DOI: 10.1039/d0cc00821d] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
158 Żesławska E, Kucwaj-Brysz K, Kincses A, Spengler G, Szymańska E, Czopek A, Marć MA, Kaczor A, Nitek W, Domínguez-Álvarez E, Latacz G, Kieć-Kononowicz K, Handzlik J. An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells. Bioorg Chem 2021;109:104735. [PMID: 33640632 DOI: 10.1016/j.bioorg.2021.104735] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
159 Li D, Hong X, Zhao F, Ci X, Zhang S. Targeting Nrf2 may reverse the drug resistance in ovarian cancer. Cancer Cell Int 2021;21:116. [PMID: 33596893 DOI: 10.1186/s12935-021-01822-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
160 Chen Y, Li Y, Huang L, Du Y, Gan F, Li Y, Yao Y. Antioxidative Stress: Inhibiting Reactive Oxygen Species Production as a Cause of Radioresistance and Chemoresistance. Oxid Med Cell Longev 2021;2021:6620306. [PMID: 33628367 DOI: 10.1155/2021/6620306] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
161 Liu XY, Wang JQ, Ashby CR Jr, Zeng L, Fan YF, Chen ZS. Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer. Drug Discov Today 2021;26:1284-92. [PMID: 33549529 DOI: 10.1016/j.drudis.2021.01.030] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 27.0] [Reference Citation Analysis]
162 Cetin R, Quandt E, Kaulich M. Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance. Cells 2021;10:260. [PMID: 33525637 DOI: 10.3390/cells10020260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Rucins M, Smits R, Sipola A, Vigante B, Domracheva I, Turovska B, Muhamadejev R, Pajuste K, Plotniece M, Sobolev A, Duburs G, Plotniece A. Pleiotropic Properties of Amphiphilic Dihydropyridines, Dihydropyridones, and Aminovinylcarbonyl Compounds. Oxid Med Cell Longev 2020;2020:8413713. [PMID: 33488932 DOI: 10.1155/2020/8413713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
164 Tang Z, Zhao P, Wang H, Liu Y, Bu W. Biomedicine Meets Fenton Chemistry. Chem Rev 2021;121:1981-2019. [DOI: 10.1021/acs.chemrev.0c00977] [Cited by in Crossref: 150] [Cited by in F6Publishing: 172] [Article Influence: 150.0] [Reference Citation Analysis]
165 Li S, Liu M, Ma H, Jin Q, Ma Y, Wang C, Ren J, Liu G, Dai Y. Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments. J Ovarian Res 2021;14:17. [PMID: 33478578 DOI: 10.1186/s13048-020-00763-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
166 Mosca L, Ilari A, Fazi F, Assaraf YG, Colotti G. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming. Drug Resist Updat 2021;54:100742. [PMID: 33429249 DOI: 10.1016/j.drup.2020.100742] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 43.0] [Reference Citation Analysis]
167 Xiao X, Wang K, Zong Q, Tu Y, Dong Y, Yuan Y. Polyprodrug with glutathione depletion and cascade drug activation for multi-drug resistance reversal. Biomaterials 2021;270:120649. [PMID: 33588139 DOI: 10.1016/j.biomaterials.2020.120649] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 24.0] [Reference Citation Analysis]
168 Martínez VR, Aguirre MV, Todaro JS, Ferrer EG, Williams PAM. Candesartan and valsartan Zn( ii ) complexes as inducing agents of reductive stress: mitochondrial dysfunction and apoptosis. New J Chem 2021;45:939-51. [DOI: 10.1039/d0nj02937h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
169 Nasrin T, Chakraborti S, Shaikh S. Reactive Species and ER-Mitochondrial Performance for Glioblastoma Multiforme Treatment Strategy. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects 2021. [DOI: 10.1007/978-981-15-4501-6_20-1] [Reference Citation Analysis]
170 Lü X, Ma Y, Tao Y, Yan F, Song C, Wang C, Zhang M. Conformers, Properties of the Anticancer Drug Plocabulin, and its Binding Mechanism with p-Glycoprotein: DFT and MD Studies. Aust J Chem 2021;74:529. [DOI: 10.1071/ch20320] [Reference Citation Analysis]
171 Williams WR. Cyclic Nucleotide Structural Differentiation of Compounds Modulating Apoptosis and Drug Resistance. JBM 2021;09:10-28. [DOI: 10.4236/jbm.2021.98002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
172 Navas LE, Carnero A. NAD+ metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther 2021;6:2. [PMID: 33384409 DOI: 10.1038/s41392-020-00354-w] [Cited by in Crossref: 61] [Cited by in F6Publishing: 70] [Article Influence: 61.0] [Reference Citation Analysis]
173 Szabo I, Zoratti M, Biasutto L. Targeting mitochondrial ion channels for cancer therapy. Redox Biol 2021;42:101846. [PMID: 33419703 DOI: 10.1016/j.redox.2020.101846] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
174 Gu X, Li X, Guan M, Jiang C, Song Q, Sun N, Zou Y, Zhou Q, Chen J, Qiu J. Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells. Bioorg Med Chem Lett 2020;30:127638. [PMID: 33132117 DOI: 10.1016/j.bmcl.2020.127638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
175 Gu X, Guan M, Jiang C, Song Q, Li X, Sun N, Chen J, Qiu J. Assessment of Thiosemicarbazone-Containing Compounds as Potential Antileukemia Agents against P-gp Overexpressing Drug Resistant K562/A02 Cells. Chem Biodivers 2021;18:e2000775. [PMID: 33314614 DOI: 10.1002/cbdv.202000775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
176 Li Q, Liu X, Yan W, Chen Y. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma. Aging (Albany NY) 2020;13:2593-603. [PMID: 33323546 DOI: 10.18632/aging.202297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Guo Q, Li X, Cui MN, Sun JL, Ji HY, Ni BB, Yan MX. CD13: A Key Player in Multidrug Resistance in Cancer Chemotherapy. Oncol Res 2020;28:533-40. [PMID: 32532363 DOI: 10.3727/096504020X15919605976853] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
178 Wang JQ, Teng QX, Lei ZN, Ji N, Cui Q, Fu H, Lin L, Yang DH, Fan YF, Chen ZS. Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase Inhibitor. Front Cell Dev Biol 2020;8:601400. [PMID: 33364237 DOI: 10.3389/fcell.2020.601400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
179 Zhai X, El Hiani Y. Getting Lost in the Cell-Lysosomal Entrapment of Chemotherapeutics. Cancers (Basel) 2020;12:E3669. [PMID: 33297435 DOI: 10.3390/cancers12123669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Shao F, Lyu X, Miao K, Xie L, Wang H, Xiao H, Li J, Chen Q, Ding R, Chen P, Xing F, Zhang X, Luo GH, Zhu W, Cheng G, Lon NW, Martin SE, Wang G, Chen G, Dai Y, Deng CX. Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA Screening. Adv Sci (Weinh) 2020;7:2001914. [PMID: 33304752 DOI: 10.1002/advs.202001914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
181 Li B, Jiang J, Assaraf YG, Xiao H, Chen Z, Huang C. Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification. Drug Resistance Updates 2020;53:100720. [DOI: 10.1016/j.drup.2020.100720] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 28.5] [Reference Citation Analysis]
182 Guieu B, Jourdan JP, Dreneau A, Willand N, Rochais C, Dallemagne P. Desirable drug-drug interactions or when a matter of concern becomes a renewed therapeutic strategy. Drug Discov Today 2021;26:315-28. [PMID: 33253919 DOI: 10.1016/j.drudis.2020.11.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Deng X, Lin N, Fu J, Xu L, Luo H, Jin Y, Liu Y, Sun L, Su J. The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer. Oxid Med Cell Longev 2020;2020:4830418. [PMID: 33294122 DOI: 10.1155/2020/4830418] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
184 Li G, Wu X, Sun P, Zhang Z, Shao E, Mao J, Cao H, Huang H. Dithiolation indolizine exerts viability suppression effects on A549 cells via triggering intrinsic apoptotic pathways and inducing G2/M phase arrest. Biomed Pharmacother 2021;133:110961. [PMID: 33190035 DOI: 10.1016/j.biopha.2020.110961] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
185 Garcia-Mayea Y, Mir C, Carballo L, Castellvi J, Temprana-Salvador J, Lorente J, Benavente S, García-Pedrero JM, Allonca E, Rodrigo JP, LLeonart ME. TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance. Cancers (Basel) 2020;12:E3269. [PMID: 33167355 DOI: 10.3390/cancers12113269] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
186 Martinefski MR, Elguero B, Knott ME, Gonilski D, Tedesco L, Gurevich Messina JM, Pollak C, Arzt E, Monge ME. Mass Spectrometry-Based Metabolic Fingerprinting Contributes to Unveil the Role of RSUME in Renal Cell Carcinoma Cell Metabolism. J Proteome Res 2021;20:786-803. [PMID: 33124415 DOI: 10.1021/acs.jproteome.0c00655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Gao HL, Gupta P, Cui Q, Ashar YV, Wu ZX, Zeng L, Lei ZN, Teng QX, Ashby CR Jr, Guan Y, Chen ZS. Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter. Front Oncol 2020;10:574861. [PMID: 33163405 DOI: 10.3389/fonc.2020.574861] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
188 Nath J, Paul R, Ghosh SK, Paul J, Singha B, Debnath N. Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects. Life Sciences 2020;258:118189. [DOI: 10.1016/j.lfs.2020.118189] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
189 Kwak AW, Lee MH, Yoon G, Cho SS, Choi JS, Chae JI, Shim JH. Deoxypodophyllotoxin, a Lignan from Anthriscus sylvestris, Induces Apoptosis and Cell Cycle Arrest by Inhibiting the EGFR Signaling Pathways in Esophageal Squamous Cell Carcinoma Cells. Int J Mol Sci 2020;21:E6854. [PMID: 32961992 DOI: 10.3390/ijms21186854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
190 Song R, Wang H, Zhang M, Liu Y, Meng X, Zhai S, Wang C, Gong T, Wu Y, Jiang X, Bu W. Near‐Infrared Light‐Triggered Chlorine Radical ( . Cl) Stress for Cancer Therapy. Angew Chem 2020;132:21218-26. [DOI: 10.1002/ange.202007434] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
191 Song R, Wang H, Zhang M, Liu Y, Meng X, Zhai S, Wang CC, Gong T, Wu Y, Jiang X, Bu W. Near-Infrared Light-Triggered Chlorine Radical (. Cl) Stress for Cancer Therapy. Angew Chem Int Ed Engl 2020;59:21032-40. [PMID: 32667130 DOI: 10.1002/anie.202007434] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 16.5] [Reference Citation Analysis]
192 Liu K, Ou J, Wang S, Gao J, Liu L, Ye Y, Wilson DA, Hu Y, Peng F, Tu Y. Magnesium-based micromotors for enhanced active and synergistic hydrogen chemotherapy. Applied Materials Today 2020;20:100694. [DOI: 10.1016/j.apmt.2020.100694] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
193 Zhao Y, Zheng W. Deciphering the antitumoral potential of the bioactive metabolites from medicinal mushroom Inonotus obliquus. J Ethnopharmacol 2021;265:113321. [PMID: 32877719 DOI: 10.1016/j.jep.2020.113321] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
194 Bouché M, Hognon C, Grandemange S, Monari A, Gros PC. Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites. Dalton Trans 2020;49:11451-66. [PMID: 32776052 DOI: 10.1039/d0dt02135k] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
195 Xue D, Zhou X, Qiu J. Emerging role of NRF2 in ROS-mediated tumor chemoresistance. Biomed Pharmacother 2020;131:110676. [PMID: 32858502 DOI: 10.1016/j.biopha.2020.110676] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
196 Wang X, Yang L, Fang Q, Xu J, Cheng X, Xue Y, Tang R. GLUT1‐Targeting and GSH‐Responsive DOX/L61 Nanodrug Particles for Enhancing MDR Breast Cancer Therapy. Part Part Syst Charact 2020;37:2000165. [DOI: 10.1002/ppsc.202000165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
197 Zhang M, Chen XY, Dong XD, Wang JQ, Feng W, Teng QX, Cui Q, Li J, Li XQ, Chen ZS. NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance. Front Oncol 2020;10:1219. [PMID: 32793491 DOI: 10.3389/fonc.2020.01219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
198 Huang G, Pan ST. ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer. Oxid Med Cell Longev 2020;2020:5047987. [PMID: 32774675 DOI: 10.1155/2020/5047987] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
199 Zhou D, Wang L, Cui Q, Iftikhar R, Xia Y, Xu P. Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia. Front Cell Dev Biol 2020;8:565. [PMID: 32766241 DOI: 10.3389/fcell.2020.00565] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
200 Pérez-Ruiz E, Melero I, Kopecka J, Sarmento-Ribeiro AB, García-Aranda M, De Las Rivas J. Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies. Drug Resist Updat 2020;53:100718. [PMID: 32736034 DOI: 10.1016/j.drup.2020.100718] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 32.5] [Reference Citation Analysis]
201 Xing C, Yin P, Peng Z, Zhang H. Engineering Mono-Chalcogen Nanomaterials for Omnipotent Anticancer Applications: Progress and Challenges. Adv Healthc Mater 2020;9:e2000273. [PMID: 32537940 DOI: 10.1002/adhm.202000273] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
202 Dal Bo M, De Mattia E, Baboci L, Mezzalira S, Cecchin E, Assaraf YG, Toffoli G. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. Drug Resistance Updates 2020;51:100702. [DOI: 10.1016/j.drup.2020.100702] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
203 Li D, Li Y. The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther 2020;5:108. [PMID: 32606298 DOI: 10.1038/s41392-020-00216-5] [Cited by in Crossref: 88] [Cited by in F6Publishing: 109] [Article Influence: 44.0] [Reference Citation Analysis]
204 Dinić J, Efferth T, García-Sosa AT, Grahovac J, Padrón JM, Pajeva I, Rizzolio F, Saponara S, Spengler G, Tsakovska I. Repurposing old drugs to fight multidrug resistant cancers. Drug Resist Updat 2020;52:100713. [PMID: 32615525 DOI: 10.1016/j.drup.2020.100713] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
205 Erin N, Grahovac J, Brozovic A, Efferth T. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resist Updat 2020;53:100715. [PMID: 32679188 DOI: 10.1016/j.drup.2020.100715] [Cited by in Crossref: 116] [Cited by in F6Publishing: 131] [Article Influence: 58.0] [Reference Citation Analysis]
206 Zhou C, Fan N, Liu F, Fang N, Plum PS, Thieme R, Gockel I, Gromnitza S, Hillmer AM, Chon SH, Schlösser HA, Bruns CJ, Zhao Y. Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer. Cells 2020;9:E1481. [PMID: 32560537 DOI: 10.3390/cells9061481] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
207 Yang Y, Ji N, Cai CY, Wang JQ, Lei ZN, Teng QX, Wu ZX, Cui Q, Pan Y, Chen ZS. Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor. Cancer Commun (Lond) 2020;40:285-300. [PMID: 32525624 DOI: 10.1002/cac2.12040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
208 Chen K, Chang C, Liu Z, Zhou Y, Xu Q, Li C, Huang Z, Xu H, Xu P, Lu B. Hyaluronic acid targeted and pH-responsive nanocarriers based on hollow mesoporous silica nanoparticles for chemo-photodynamic combination therapy. Colloids Surf B Biointerfaces 2020;194:111166. [PMID: 32521461 DOI: 10.1016/j.colsurfb.2020.111166] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
209 Luo Y, Qiao B, Zhang P, Yang C, Cao J, Yuan X, Ran H, Wang Z, Hao L, Cao Y, Ren J, Zhou Z. TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy. Theranostics 2020;10:6987-7001. [PMID: 32550917 DOI: 10.7150/thno.44569] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
210 Movahedi F, Wu Y, Gu W, Xu ZP. Nanostructuring a Widely Used Antiworm Drug into the Lipid-Coated Calcium Phosphate Matrix for Enhanced Skin Tumor Treatment. ACS Appl Bio Mater 2020;3:4230-8. [DOI: 10.1021/acsabm.0c00313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
211 Ferraz APCR, Sussulini A, Garcia JL, Costa MR, Francisqueti-Ferron FV, Ferron AJT, Silva CCVA, Corrente JE, Manfio VM, Namba V, Lima GPP, Pereira BS, Fecchio D, Minatel IO, Dos Santos KC, Corrêa CR. Hydroethanolic Extract of Solanum paniculatum L. Fruits Modulates ROS and Cytokine in Human Cell Lines. Oxid Med Cell Longev 2020;2020:7240216. [PMID: 32411334 DOI: 10.1155/2020/7240216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
212 Jun F, Peng Z, Zhang Y, Shi D. Quantitative Proteomic Profiling Identifies SOX8 as Novel Regulator of Drug Resistance in Gestational Trophoblastic Neoplasia. Front Oncol 2020;10:557. [PMID: 32411596 DOI: 10.3389/fonc.2020.00557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
213 Peng X, Li C, Yu W, Liu S, Cong Y, Fan G, Qi S. Propofol Attenuates Hypoxia-Induced Inflammation in BV2 Microglia by Inhibiting Oxidative Stress and NF-κB/Hif-1α Signaling. Biomed Res Int 2020;2020:8978704. [PMID: 32420378 DOI: 10.1155/2020/8978704] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
214 Xie W, Tan B, Yang Z, Yu X, Chen L, Ran D, Xu Q, Zhou X. Nrf2/ARE pathway activation is involved in negatively regulating heat-induced apoptosis in non-small cell lung cancer cells. Acta Biochim Biophys Sin (Shanghai) 2020;52:439-45. [PMID: 32255482 DOI: 10.1093/abbs/gmaa013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
215 Jun F, Peng Z, Zhang Y, Shi D. Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma. Gynecologic Oncology 2020;157:268-79. [DOI: 10.1016/j.ygyno.2020.01.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
216 Zhao Y, Luo Q, Mo J, Li J, Ye D, Ao Z, Chen L, Liu J. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks. J Cancer 2020;11:3701-12. [PMID: 32328174 DOI: 10.7150/jca.36372] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
217 Wang S, Li H, Chen S, Wang Z, Yao Y, Chen T, Ye Z, Lin P. Andrographolide induces apoptosis in human osteosarcoma cells via the ROS/JNK pathway. Int J Oncol 2020;56:1417-28. [PMID: 32236589 DOI: 10.3892/ijo.2020.5032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
218 Xu T, Ma Y, Yuan Q, Hu H, Hu X, Qian Z, Rolle JK, Gu Y, Li S. Enhanced Ferroptosis by Oxygen-Boosted Phototherapy Based on a 2-in-1 Nanoplatform of Ferrous Hemoglobin for Tumor Synergistic Therapy. ACS Nano 2020;14:3414-25. [PMID: 32155051 DOI: 10.1021/acsnano.9b09426] [Cited by in Crossref: 97] [Cited by in F6Publishing: 112] [Article Influence: 48.5] [Reference Citation Analysis]
219 An H, Guo C, Li D, Liu R, Xu X, Guo J, Ding J, Li J, Chen W, Zhang J. Hydrogen Peroxide-Activatable Nanoparticles for Luminescence Imaging and In Situ Triggerable Photodynamic Therapy of Cancer. ACS Appl Mater Interfaces 2020;12:17230-43. [DOI: 10.1021/acsami.0c01413] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 15.0] [Reference Citation Analysis]
220 Song WP, Zheng S, Yao HJ, Zhou XF, Li R, Zhang CY, Zhao JY, Wang LW, Shao RG, Li L. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. BMC Ophthalmol 2020;20:92. [PMID: 32143590 DOI: 10.1186/s12886-020-01348-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
221 Cao X, Hou J, An Q, Assaraf YG, Wang X. Towards the overcoming of anticancer drug resistance mediated by p53 mutations. Drug Resistance Updates 2020;49:100671. [DOI: 10.1016/j.drup.2019.100671] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 31.0] [Reference Citation Analysis]
222 Fumarola S, Cecati M, Sartini D, Ferretti G, Milanese G, Galosi AB, Pozzi V, Campagna R, Morresi C, Emanuelli M, Bacchetti T. Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression. Antioxidants (Basel) 2020;9:E175. [PMID: 32093309 DOI: 10.3390/antiox9020175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
223 Wang JQ, Li JY, Teng QX, Lei ZN, Ji N, Cui Q, Zeng L, Pan Y, Yang DH, Chen ZS. Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells. Cancers (Basel) 2020;12:E466. [PMID: 32085398 DOI: 10.3390/cancers12020466] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
224 Xin ZH, Meng YL, Jiang WJ, Li YP, Ge LP, Zhang CH, Liu LN, Kang YF. Finding an efficient tetramethylated hydroxydiethylene of resveratrol analogue for potential anticancer agent. BMC Chem 2020;14:13. [PMID: 32099972 DOI: 10.1186/s13065-020-00667-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
225 Bae SY, Liao L, Park SH, Kim WK, Shin J, Lee SK. Antitumor Activity of Asperphenin A, a Lipopeptidyl Benzophenone from Marine-Derived Aspergillus sp. Fungus, by Inhibiting Tubulin Polymerization in Colon Cancer Cells. Mar Drugs 2020;18:E110. [PMID: 32069904 DOI: 10.3390/md18020110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
226 Guo W, Tan HY, Chen F, Wang N, Feng Y. Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines. Cancers (Basel) 2020;12:E404. [PMID: 32050640 DOI: 10.3390/cancers12020404] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
227 Dong J, Qin Z, Zhang WD, Cheng G, Yehuda AG, Ashby CR Jr, Chen ZS, Cheng XD, Qin JJ. Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update. Drug Resist Updat 2020;49:100681. [PMID: 32014648 DOI: 10.1016/j.drup.2020.100681] [Cited by in Crossref: 104] [Cited by in F6Publishing: 111] [Article Influence: 52.0] [Reference Citation Analysis]
228 Chen M, Yang J, Li L, Hu Y, Lu X, Sun R, Wang Y, Wang X, Zhang X. Metabolomics Reveals that Cysteine Metabolism Plays a Role in Celastrol-Induced Mitochondrial Apoptosis in HL-60 and NB-4 Cells. Sci Rep 2020;10:471. [PMID: 31949255 DOI: 10.1038/s41598-019-57312-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
229 Costea T, Vlad OC, Miclea LC, Ganea C, Szöllősi J, Mocanu MM. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. Int J Mol Sci 2020;21:E401. [PMID: 31936346 DOI: 10.3390/ijms21020401] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
230 Tian Y, Gong G, Ma L, Wang Z, Song D, Fang M. Anti-cancer effects of Polyphyllin I: An update in 5 years. Chemico-Biological Interactions 2020;316:108936. [DOI: 10.1016/j.cbi.2019.108936] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
231 Andrei L, Kasas S, Ochoa Garrido I, Stanković T, Suárez Korsnes M, Vaclavikova R, Assaraf YG, Pešić M. Advanced technological tools to study multidrug resistance in cancer. Drug Resistance Updates 2020;48:100658. [DOI: 10.1016/j.drup.2019.100658] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
232 郭 牡. Research Progress of Multidrug Resistance Mechanism and Reverser in Tumor. JOCR 2020;08:1-13. [DOI: 10.12677/jocr.2020.81001] [Reference Citation Analysis]
233 Li M, Zhang H, Hou Y, Wang X, Xue C, Li W, Cai K, Zhao Y, Luo Z. State-of-the-art iron-based nanozymes for biocatalytic tumor therapy. Nanoscale Horiz 2020;5:202-17. [DOI: 10.1039/c9nh00577c] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 23.5] [Reference Citation Analysis]
234 Narayanan S, Cai C, Assaraf YG, Guo H, Cui Q, Wei L, Huang J, Ashby CR, Chen Z. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance. Drug Resistance Updates 2020;48:100663. [DOI: 10.1016/j.drup.2019.100663] [Cited by in Crossref: 90] [Cited by in F6Publishing: 101] [Article Influence: 45.0] [Reference Citation Analysis]
235 Cheng K, Ling C, Gu D, Gao Z, Li Y, An P, Zhang Y, You C, Zhang R, Sun B. Multimodal therapies: glucose oxidase-triggered tumor starvation-induced synergism with enhanced chemodynamic therapy and chemotherapy. New J Chem 2020;44:1524-36. [DOI: 10.1039/c9nj05469c] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
236 Mrakovcic M, Fröhlich LF. Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy. Cancers (Basel) 2019;12:E109. [PMID: 31906235 DOI: 10.3390/cancers12010109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
237 Yan L, Lin M, Pan S, Assaraf YG, Wang ZW, Zhu X. Emerging roles of F-box proteins in cancer drug resistance. Drug Resist Updat 2020;49:100673. [PMID: 31877405 DOI: 10.1016/j.drup.2019.100673] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
238 Park S, Kim H, Ji HW, Kim HW, Yun SH, Choi EH, Kim SJ. Cold Atmospheric Plasma Restores Paclitaxel Sensitivity to Paclitaxel-Resistant Breast Cancer Cells by Reversing Expression of Resistance-Related Genes. Cancers (Basel) 2019;11:E2011. [PMID: 31847101 DOI: 10.3390/cancers11122011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
239 Wang J, Wang B, Lei Z, Teng Q, Li JY, Zhang W, Ji N, Cai C, Ma L, Liu H, Chen Z. Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance. European Journal of Pharmacology 2019;863:172611. [DOI: 10.1016/j.ejphar.2019.172611] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
240 Duan FG, Wang MF, Cao YB, Dan Li, Li RZ, Fan XX, Khan I, Lai HL, Zhang YZ, Hsiao WW, Yao XJ, Wu QB, Liu L, Tang YJ, Leung EL. MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer. Cell Death Dis 2019;10:821. [PMID: 31659154 DOI: 10.1038/s41419-019-2031-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
241 Tolios A, De Las Rivas J, Hovig E, Trouillas P, Scorilas A, Mohr T. Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions. Drug Resist Updat 2020;48:100662. [PMID: 31927437 DOI: 10.1016/j.drup.2019.100662] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
242 Wu M, Ding Y, Li L. Recent progress in the augmentation of reactive species with nanoplatforms for cancer therapy. Nanoscale. 2019;11:19658-19683. [PMID: 31612164 DOI: 10.1039/c9nr06651a] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 19.0] [Reference Citation Analysis]
243 Kim EK, Jang M, Song MJ, Kim D, Kim Y, Jang HH. Redox-Mediated Mechanism of Chemoresistance in Cancer Cells. Antioxidants (Basel) 2019;8:E471. [PMID: 31658599 DOI: 10.3390/antiox8100471] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 18.0] [Reference Citation Analysis]
244 Wei X, Yang Y, Ge J, Lin X, Liu D, Wang S, Zhang J, Zhou G, Li S. Synthesis, characterization, DNA/BSA interactions and in vitro cytotoxicity study of palladium(II) complexes of hispolon derivatives. J Inorg Biochem 2020;202:110857. [PMID: 31669695 DOI: 10.1016/j.jinorgbio.2019.110857] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
245 Dasgupta S. Mitochondrion: I am more than a fuel server. Ann Transl Med 2019;7:594. [PMID: 31807575 DOI: 10.21037/atm.2019.08.22] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
246 Zhou R, Wang P, Guo Y, Dai X, Xiao S, Fang Z, Speight R, Thompson EW, Cullen PJ, Ostrikov KK. Prussian blue analogue nanoenzymes mitigate oxidative stress and boost bio-fermentation. Nanoscale 2019;11:19497-505. [PMID: 31553036 DOI: 10.1039/c9nr04951g] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
247 Zheng W, Boada R, He R, Xiao T, Ye F, Simonelli L, Valiente M, Zhao Y, Hassan M. Extracellular Albumin Covalently Sequesters Selenocompounds and Determines Cytotoxicity. Int J Mol Sci 2019;20:E4734. [PMID: 31554226 DOI: 10.3390/ijms20194734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
248 Xian D, Lai R, Song J, Xiong X, Zhong J. Emerging Perspective: Role of Increased ROS and Redox Imbalance in Skin Carcinogenesis. Oxid Med Cell Longev 2019;2019:8127362. [PMID: 31636809 DOI: 10.1155/2019/8127362] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
249 Leonetti A, Wever B, Mazzaschi G, Assaraf YG, Rolfo C, Quaini F, Tiseo M, Giovannetti E. Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer. Drug Resistance Updates 2019;46:100644. [DOI: 10.1016/j.drup.2019.100644] [Cited by in Crossref: 83] [Cited by in F6Publishing: 89] [Article Influence: 27.7] [Reference Citation Analysis]
250 Cui Q, Cai CY, Wang JQ, Zhang S, Gupta P, Ji N, Yang Y, Dong X, Yang DH, Chen ZS. Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells. Int J Mol Sci 2019;20:E4095. [PMID: 31443367 DOI: 10.3390/ijms20174095] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
251 Huang Y, Shao Y, Zhu Y. Sustained reactive oxygen species generation from percarbamide nanomedicine via a mechanism of X-Ray-initiated free radical chain reactions. J Biomater Appl 2019;34:728-38. [PMID: 31411100 DOI: 10.1177/0885328219868851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
252 Li S, Liao R, Sheng X, Luo X, Zhang X, Wen X, Zhou J, Peng K. Hydrogen Gas in Cancer Treatment. Front Oncol 2019;9:696. [PMID: 31448225 DOI: 10.3389/fonc.2019.00696] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
253 Xu X, Feng Y, Chen X, Wang Q, Meng T, Liu A. Antitumor effects of seleno-β-lactoglobulin on human breast cancer MCF-7 and MDA-MB-231 cells in vitro. Toxicol In Vitro 2019;61:104607. [PMID: 31348985 DOI: 10.1016/j.tiv.2019.104607] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
254 Fan Z, Xu H. Recent Progress in the Biological Applications of Reactive Oxygen Species-Responsive Polymers. Polymer Reviews 2020;60:114-43. [DOI: 10.1080/15583724.2019.1641515] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
255 Ye Q, Liu K, Shen Q, Li Q, Hao J, Han F, Jiang RW. Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids. Front Oncol 2019;9:487. [PMID: 31245292 DOI: 10.3389/fonc.2019.00487] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 24.0] [Reference Citation Analysis]
256 Meel MH, Kaspers GJL, Hulleman E. Preclinical therapeutic targets in diffuse midline glioma. Drug Resist Updat 2019;44:15-25. [PMID: 31202081 DOI: 10.1016/j.drup.2019.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
257 Wu Y, Guo T, Qiu Y, Lin Y, Yao Y, Lian W, Lin L, Song J, Yang H. An inorganic prodrug, tellurium nanowires with enhanced ROS generation and GSH depletion for selective cancer therapy. Chem Sci 2019;10:7068-75. [PMID: 31588274 DOI: 10.1039/c9sc01070j] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 16.3] [Reference Citation Analysis]
258 Yao Z, Zhang B, Liang T, Ding J, Min Q, Zhu JJ. Promoting Oxidative Stress in Cancer Starvation Therapy by Site-Specific Startup of Hyaluronic Acid-Enveloped Dual-Catalytic Nanoreactors. ACS Appl Mater Interfaces 2019;11:18995-9005. [PMID: 31058483 DOI: 10.1021/acsami.9b06034] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 20.0] [Reference Citation Analysis]
259 Cui Q, Cai CY, Gao HL, Ren L, Ji N, Gupta P, Yang Y, Shukla S, Ambudkar SV, Yang DH, Chen ZS. Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells. Front Oncol 2019;9:313. [PMID: 31106148 DOI: 10.3389/fonc.2019.00313] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
260 An Y, Zhou L, Huang Z, Nice EC, Zhang H, Huang C. Molecular insights into cancer drug resistance from a proteomics perspective. Expert Rev Proteomics 2019;16:413-29. [PMID: 30925852 DOI: 10.1080/14789450.2019.1601561] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
261 Xing Y, Ding T, Wang Z, Wang L, Guan H, Tang J, Mo D, Zhang J. Temporally Controlled Photothermal/Photodynamic and Combined Therapy for Overcoming Multidrug Resistance of Cancer by Polydopamine Nanoclustered Micelles. ACS Appl Mater Interfaces 2019;11:13945-53. [PMID: 30907570 DOI: 10.1021/acsami.9b00472] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 20.0] [Reference Citation Analysis]
262 Wang K, Jiang J, Lei Y, Zhou S, Wei Y, Huang C. Targeting Metabolic-Redox Circuits for Cancer Therapy. Trends Biochem Sci 2019;44:401-14. [PMID: 30679131 DOI: 10.1016/j.tibs.2019.01.001] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 27.7] [Reference Citation Analysis]
263 Gupta P, Gao HL, Ashar YV, Karadkhelkar NM, Yoganathan S, Chen ZS. Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates. Int J Mol Sci 2019;20:E268. [PMID: 30641875 DOI: 10.3390/ijms20020268] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]